Cardiomyopathy
HCM Risk-SCD
ESC HCM Risk-SCD model for adults (≥ 16 years) with hypertrophic cardiomyopathy, supplemented by AHA/ACC 2024 major risk markers.
Upload a report, lab sheet or echo picture to fill this calculator automatically.
Measurements
Echo at first evaluation
Clinical risk factors
Included in HCM Risk-SCD
Additional risk markers
Not in the formula — modify the decision (ESC 2023 / AHA-ACC 2024)
HCM Risk-SCD · 5-year SCD risk
Enter age, wall thickness, LA size and LVOT gradient.
Save / print: on this device only, nothing is uploaded
References
- O'Mahony C, et al. A novel clinical risk prediction model for sudden cardiac death in HCM (HCM Risk-SCD). Eur Heart J 2014;35:2010-2020.
- Arbelo E, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503-3626.
- Ommen SR, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the management of hypertrophic cardiomyopathy. Circulation 2024;149:e1239-e1311.